SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19364964
Source:
http://linkedlifedata.com/resource/pubmed/id/19364964
Search
Subject
(
64
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0006142
,
umls-concept:C0205225
,
umls-concept:C0205539
,
umls-concept:C1707455
,
umls-concept:C2347669
pubmed:issue
18
pubmed:dateCreated
2009-6-22
pubmed:abstractText
To compare preoperative intense dose-dense (IDD) chemotherapy with conventionally scheduled preoperative chemotherapy in high-risk primary breast cancer (BC).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antibiotics, Antineoplastic
,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic
,
http://linkedlifedata.com/resource/pubmed/chemical/Epirubicin
,
http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1527-7755
pubmed:author
pubmed-author:AlbertUte-SusannUS
,
pubmed-author:BauerfeindIngoI
,
pubmed-author:HarbeckNadiaN
,
pubmed-author:HinkeAxelA
,
pubmed-author:JänickeFritzF
,
pubmed-author:KahlertStephenS
,
pubmed-author:KonecnyGottfried EGE
,
pubmed-author:KreienbergRolfR
,
pubmed-author:KuhnWaltherW
,
pubmed-author:LückHans-JoachimHJ
,
pubmed-author:LebeauAnnetteA
,
pubmed-author:MöbusVolkerV
,
pubmed-author:MuckBernd RudolphBR
,
pubmed-author:PetryKarl UlrichKU
,
pubmed-author:SchneeweissAndreasA
,
pubmed-author:ThomssenChristophC
,
pubmed-author:UntchMichaelM
,
pubmed-author:WallwienerDiethelmD
,
pubmed-author:WernerChristophC
,
pubmed-author:von KochFranzF
pubmed:issnType
Electronic
pubmed:day
20
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2938-45
pubmed:meshHeading
pubmed-meshheading:19364964-Antibiotics, Antineoplastic
,
pubmed-meshheading:19364964-Antineoplastic Agents, Phytogenic
,
pubmed-meshheading:19364964-Breast Neoplasms
,
pubmed-meshheading:19364964-Disease-Free Survival
,
pubmed-meshheading:19364964-Drug Therapy, Combination
,
pubmed-meshheading:19364964-Epirubicin
,
pubmed-meshheading:19364964-Female
,
pubmed-meshheading:19364964-Humans
,
pubmed-meshheading:19364964-Middle Aged
,
pubmed-meshheading:19364964-Paclitaxel
,
pubmed-meshheading:19364964-Prognosis
,
pubmed-meshheading:19364964-Treatment Outcome
pubmed:year
2009
pubmed:articleTitle
Intensive dose-dense compared with conventionally scheduled preoperative chemotherapy for high-risk primary breast cancer.
pubmed:affiliation
Helios Klinikum, Campus Berlin Buch, Berlin, Germany.
pubmed:publicationType
Journal Article
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Clinical Trial, Phase III